Clinical Trials on Chronic Obstructive Pulmonary Syndrom in United Kingdom

Total 3952 results

GlaxoSmithKline

Completed

A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium

Pulmonary Disease, Chronic Obstructive

United States, United Kingdom
Theravance Biopharma
GlaxoSmithKline; Hammersmith Medicines Research

Completed

A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

RELOVAIR® Lung Deflation Study

Pulmonary Disease, Chronic Obstructive

United Kingdom
University of Leeds
The Leeds Teaching Hospitals NHS Trust

Recruiting

Evaluating Treatable Traits Across the Spectrum of Chronic Obstructive Airways Disease

Airway Disease

United Kingdom
Minneapolis Veterans Affairs Medical Center

Completed

Effect of Supplemental Vitamin D on Skeletal Muscle Function in Chronic Obstructive Pulmonary Disease (COPD) Patients

Chronic Obstructive Pulmonary Disease (COPD)

United States
GlaxoSmithKline

Completed

Study of Safety and Drug Levels of CCI15106 Inhalation Powder in Healthy Adults and Adults With Moderate Chronic Obstructive Pulmonary Disease. Study of CCI15106 Levels in People Standing Near the Person Inhaling the Drug

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca

Recruiting

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD). (ATHLOS)

Chronic Obstructive Pulmonary Disease

Germany, Spain, United States, China, Korea, Republic of, Argentina, United Kingdom, Canada
Canandaigua VA Medical Center

Recruiting

Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease.

Chronic Obstructive Pulmonary Disease Moderate

United States
Strados Labs, Inc.

Withdrawn

Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
University of Pennsylvania

Terminated

A Prospective, Cohort Study of Hyperpolarized 3He MRI in Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Astellas Pharma Global Development, Inc.
Cytokinetics

Completed

A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States
Philips Healthcare

Completed

Validation of Medication Non-adherence Model (UK)

Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Chronic Illness | Primary Care | Medication Management at Home

United Kingdom
Ionis Pharmaceuticals, Inc.

Terminated

A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)

Chronic Obstructive Pulmonary Disease | Chronic Bronchitis

Germany, Czechia, Hungary, United Kingdom
Mylan Inc.
Theravance Biopharma

Completed

A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Mylan Inc.
Theravance Biopharma

Completed

Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD) (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Memorial Hospital of Rhode Island
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Translating The GOLD COPD Guidelines Into Primary Care Practice (LungAge)

Chronic Obstructive Pulmonary Disease (COPD)

United States
AstraZeneca
University of Oxford

Completed

Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD Patients (CORAL)

Pulmonary Disease, Chronic Obstructive

United Kingdom
University of California, San Diego

Completed

Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSA

Chronic Obstructive Pulmonary Disease | Obstructive Sleep Apnea | Overlap Syndrome

United States
GlaxoSmithKline

Completed

Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma

Pulmonary Disease, Chronic Obstructive

United Kingdom
Sheffield Teaching Hospitals NHS Foundation Trust

Completed

Feasibility of Inspiratory Muscle Training in People With COPD Who Decline Pulmonary Rehabilitation

Pulmonary Disease, Chronic Obstructive

United Kingdom
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Virginia Commonwealth University
Fisher and Paykel Healthcare

Completed

The Effect of Humidification on Mucus Rheology

Chronic Obstructive Pulmonary Disease(COPD)

United States
Optimum Patient Care
Respiratory Effectiveness Group; Boehringer Ingelheim Pharmaceutical Company... and other collaborators

Unknown

Advancing the Patient Experience in Chronic Obstructive Pulmonary Disease (APEX COPD) (APEX COPD)

Chronic Obstructive Pulmonary Disease (13645005)

United States
Chelsea and Westminster NHS Foundation Trust

Completed

Bronchoscopic Lung Volume Reduction Using Blood

Emphysema

United Kingdom
Henry Ford Health System

Completed

Pre-Discharge Bundle for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease to Reduce Readmissions

Chronic Obstructive Pulmonary Disease | Exacerbation of Chronic Obstructive Pulmonary Disease

United States
Augusta University

Completed

Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease (COPD-LT)

Chronic Obstructive Pulmonary Disease (COPD)

United States
GlaxoSmithKline
ICON plc

Completed

FF/UMEC/VI Inhaler: Qualitative Analysis and Subject Preference Survey

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Optimising the Propranolol Block Model

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Repeat Doses of the Dry Powder Formulation of GSK2269557 in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
Chiesi Farmaceutici S.p.A.

Completed

Study to Investigate the Effect of Formoterol vs Salmeterol on Small Airways Physiological Parameters in COPD Patients (Imperial)

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca

Completed

Pharmacokinetic, Safety and Tolerability Study of Aclidinium/Formoterol Fixed Dose Combination and Formoterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Chiesi Farmaceutici S.p.A.

Completed

Randomized Cross Over Study to Assess Efficacy and Safety of BDP/FF and Glycopyrrolate

Pulmonary Disease, Chronic Obstructive

United Kingdom
Boehringer Ingelheim

Completed

Effectiveness of Triple Therapy in COPD

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Blood Levels and Effects of GSK1325756 in Healthy Adult Volunteers Aged 40 to 80 Years Old

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca
RTI Health Solutions

Recruiting

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints (PASS)

Pulmonary Disease, Chronic Obstructive

United Kingdom
Theravance Biopharma
GlaxoSmithKline

Completed

Succinate Salt Version of GSK961081 for Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca

Completed

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Study To Examine Safety, Tolerability And Pharmacokinetics Of Intravenous Doses And Oral Dose Of GSK233705

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

To Assess the Excretion Balance and Pharmacokinetics of a Single Oral Dose of [14C]GW856553 in Healthy Adult Males

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study To Evaluate The Safety And Tolerability Of SB-656933-AAA Following Repeated Doses In Healthy Adult Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

First Time in Human Study With GSK1325756

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

Pharmacokinetic and Safety of GSK573719 and GW642444 Administered Individually and Concurrently, With Verapamilin in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United Kingdom
GlaxoSmithKline

Completed

A Study to Look at How GSK1325756 is Taken up by the Body When Given by Mouth When Stomach Acid is Reduced

Pulmonary Disease, Chronic Obstructive

United Kingdom
AstraZeneca
Quintiles, Inc.

Completed

Adherence Study in COPD Patients

Chronic Obstructive Pulmonary Disease (COPD

United States
Edmond Pharma

Unknown

The Efficacy and Safety of Erdosteine in Chronic Obstructive Pulmonary Disease (COPD) (RESTORE)

Chronic Obstructive Pulmonary Disease (COPD)

Belgium, Bulgaria, Czech Republic, Denmark, France, Italy, Poland, Romania, Slovakia, United Kingdom
Beth Israel Deaconess Medical Center
National Institutes of Health (NIH); National Center for Complementary and...

Completed

BEAM COPD: Breathing, Education, Awareness and Movement in Chronic Obstructive Pulmonary Disease (COPD) (BEAM COPD)

Chronic Obstructive Pulmonary Disease (COPD)

United States
Novartis Pharmaceuticals

Completed

Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

Chronic Obstructive Pulmonary Disease (COPD)

Colombia, India, Korea, Republic of, Poland, Croatia, Estonia, Hungary, United Kingdom, Israel, Latvia, Turkey, Argentina, Panama, Mexico, Russian Federation, Serbia, Slovenia
Nephron Pharmaceuticals Corporation
Rho, Inc.

Completed

Tiotropium Bromide Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease (COPD)

United States

Clinical Trials on Chronic Obstructive Pulmonary Syndrom in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations